News
NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback